Dr. Shyam Natarajan on Unfold AI and prostate cancer

On this video, Shyam Natarajan, PhD, discusses the sensible implementation of AI-generated most cancers maps in medical settings. He’s an creator of the current BJUI Compass research, “Extracapsular extension danger evaluation utilizing a man-made intelligence prostate most cancers mapping algorithm.” Natarajan is the founder and CEO of Avenda Well being.

Transcription:

How do you envision the sensible implementation of AI-generated most cancers maps in medical settings? What are the potential challenges and limitations to widespread adoption?

We see use of AI-generated most cancers maps within the decision-making means of understanding who’s the precise affected person for what remedy, in addition to planning out the precise remedy, whether or not it is a whole-gland or a focused remedy. The findings from the research that was simply printed may very well be indicative that Unfold AI might enhance or assist type of that sub stratification of who may probably get a nerve-sparing surgical procedure vs a non-nerve-sparing surgical procedure, or who’s a greater candidate for focused remedy right here. One of many key challenges or limitations that we’re overcoming is that in an effort to run or develop this AI-generated map, the affected person should obtain a focused prostate biopsy with an image-guided prostate fusion system. And whereas this expertise is widespread, it isn’t common. So we see this, particularly with the issuance of latest classes of codes for biopsy and fusion biopsy which might be going to happen within the subsequent couple of years, we’re on the trail to sufferers universally receiving the best-in-class prognosis, after which we see AI including on high of that to provide sufferers a customized decision-making platform and assist paradigm.

This transcript was edited for readability.